Volume 26, Issue 9 (12-2019)
RJMS 2019, 26(9): 88-101 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Arasteh Z, Azadi M. Evaluation of the effect of neurofeedback on quality of life and anxiety in patients with multiple sclerosis. RJMS 2019; 26 (9) :88-101
URL: http://rjms.iums.ac.ir/article-1-5607-en.html
URL: http://rjms.iums.ac.ir/article-1-5607-en.html
Department of Psychology and Counseling, Faculty of Psychology and Educational, Islamic Azad University, South Tehran Branch, Tehran, Iran , mehran.azadi@gmail.com
Abstract: (3087 Views)
Background: Multiple sclerosis (MS) is a neurological disorder with negative effect on many areas of functional activity. The purpose of this study was to evaluate the effectiveness of neurofeedback on quality of life and anxiety in patients with MS.
Methods: This study was quasi-experimental that carried out with pre-test-post-test design with control group. The research population included MS patients referred to specialized clinics that 30 of whom had criteria for entering the research were randomly assigned into experimental and control groups. The quality of life scale (SF-36) and the anxiety-Spielberger scale were used as research tools. The subjects underwent a one-day trial under neurofeedback intervention in a 15-session period, 40 minutes with the alpha / theta protocol, and the control group did not receive intervention.
Results: The results of covariance analysis showed that neurofeedback exercises were successful in increasing the subscales of quality of life and reducing anxiety (p<0.01), while not having a significant effect on the reduction of the constraints caused by playing role.
Conclusion: Based on these findings, it can be concluded that the neurofeedback exercises used in this study can be used as a complementary and effective treatment to improve the quality of life and reduce the anxiety of MS patients.
Methods: This study was quasi-experimental that carried out with pre-test-post-test design with control group. The research population included MS patients referred to specialized clinics that 30 of whom had criteria for entering the research were randomly assigned into experimental and control groups. The quality of life scale (SF-36) and the anxiety-Spielberger scale were used as research tools. The subjects underwent a one-day trial under neurofeedback intervention in a 15-session period, 40 minutes with the alpha / theta protocol, and the control group did not receive intervention.
Results: The results of covariance analysis showed that neurofeedback exercises were successful in increasing the subscales of quality of life and reducing anxiety (p<0.01), while not having a significant effect on the reduction of the constraints caused by playing role.
Conclusion: Based on these findings, it can be concluded that the neurofeedback exercises used in this study can be used as a complementary and effective treatment to improve the quality of life and reduce the anxiety of MS patients.
Type of Study: Research |
Subject:
Clinical Psychiatry
References
1. 1. Sadock BJ, Sadock VA. Pedro R. Editors, Kaplan and Sadock's synopsis of psychiatry. Beh Sci /Plin Psychiy. 2015, 15 th ed. North American: Lippincott Williams & Wilkinsp.
2. 2. Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev. 2009;29:141-153.
3. 3. Hakim EA, Bakheit AMO, Bryantoe TN, Roberts MWH., McIntosh-Michaelis SA, Spackman AJ, et al. The social impact of multiplesclerosis-a study of 305 patients and their relatives. Disab and Rehab. 2000;22:288-93.
4. 4. Feinstein A. Mood disorders in multiple sclerosis and the effects on cognition. J Neu Sci. 2006;245: 63-6.
5. 5. Habek M, Brinar M, Brinar VV, Poser MC. Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis. Clini Neu. 2006;108:290-94.
6. 6. Romagosa C. Women confronting the reality of multiple sclerosis: A Qualitative model of self-healing, PhD, Dissertation, 2010, The University of Utah USA.
7. 7. Mitchell A, Benito-Leon J, Morales Ganzalez MJ, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lan Neu. 2005;4:556-66.
8. 8. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic sudy of a large community sample. Am J of Psychi. 2002;159:1862-1868.
9. 9. Barbotte E, Guillemin F, Chau N. Prevalence of impairments, disabilities, handicaps and quality of life in general population: Rev of recent literature. Bull World Health Organ. 2001;79(11):1042-56.
10. 10. Najafian J. [The effect of two methods of relaxation and relaxation of biofeedback on anxiety and stress in patients with mild hypertension]. J of Jahrom Uni Med Sci. 2015; 9(2):12-8. (Persian)
11. 11. Gruzelier J, Egner T, Vernon D. validating the efficacy of Neurofeedback for optimising performance. Prog Brain Res. 2006;159:421-431.
12. 12. Kouijzer MEJ, de Moor JMH, Gerrits BJL, Congedo M, van Schie HT. Neurofeedback improves executive functioning in children with autism spectrum disorders. Res Autism Spec Dis. 2009;3 (1):145-162.
13. 13. Schwartz MS, Andrasikif F. (Eds.) Biofeedback: A practitioner’s guide (3rd ed). 2003, New York: Guilford Press.
14. 14. Domos JN. Getting Started with Neurofeedback. www. Norton & company.inc: 2005, Norton.
15. 15. Gunkelman JD, Johnstone J. Neurofeedback and the brain. J Adult Devel. 2005;12(2-3):93-98.
16. 16. Staufenbiel SM, Brouwer AM, Keizez AW, Van wouwe NC. Effect of beta and gamma neurofeedback on memory and intelligence in the elderly. J Bio Psychol. 2013;95:74-85.
17. 17. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurosurg Psychi. 2005;76469-475.
18. 18. Costa MA, Gadea M, Hidalgo V, Pérez V, Sanjuán J. "An effective Neurofeedback training, with cortisol correlates, in a clinical case of anxiety". Uni Psychol. 2017;15(5). (English)
19. 19. De Andres C, Gullem A. An approach to Quality of life changes in patient with multiple sclerosis. Rev Neu. 2000;30(12):1229-1234.
20. 20. Fernandez M, Colodro-conde L, Hartvigsen J, Ferreira ML, Refshauge KM, Pinheiro MB, et al. “Chronic low back pain and the risk of depression or anxiety symptoms: insights from a longitudinal twin study”. The Spine J. 2017; 2(32):31-43.
21. 21. Nainian MR, Babapour J, Grossi Taghi, Shori MR, Rostami R. [Comparison of the effect of neurofeedback and drug therapy on reducing anxiety and quality of life in patients with anxiety disorder]. Clini Psychol Person. 2012;19(7):11-23. (Persian).
22. 22. Reiter K. Neurofeedback treatment and posttraumatic stress disorder: Effectiveness of neurofeedback on posttraumatic stress disorder and the optimal choice of protocol. J Ner Men Dis. 2016;204(2):69-77.
23. 23. Ghaior Kazemi F, Sepehri Shamloo Z, Mashhadi A, Ghanai Chaman Abad A, Pasalar F. [Comparison of the effectiveness of metacognitive therapy and neurofeedback education on meta-cognitive and anxiety beliefs in girls with generalized anxiety]. J Clin Psychol Person. 2016;19(7):4-1. (Persian)
24. 24. Rouhi Gh, Rahmani H, Abdollahi AA, Mahmoudi Gh. [The Effect of Music on Anxiety and Some Physiological Variables of Patients before Abdominal Surgery]. J of Gorgan Uni of Med Sci. 2005;7(1):78-75. (Persian)
25. 25. Ware JE, Kosinski M. SF-36 physical and mental health summary scales: A manual for users of version 1 (2nd ed). Lincoln, 2001, RI: Quality Metric
26. Incorporated.
27. 26. Montazeri, A, Gostasbi A, Vojdani Niya M. [Translation, determining the Reliability and Validity of the Persian Species of the SF-36 Questionnaire]. Payesh J. 2005;5(1):56-49. (Persian)
28. 27. Hammond DC. "What is neurofeedback: An update". J Neu. 2011;15(4):305-336.
29. 28. Moore NC. A review of EEG biofeedback treatment of anxiety disorders. Clin EEG. 2000;31(1):1-6.
30. 29. Aghaei M, Gesel S, Zeinali M, Ahmadi N, Mirzaie Sh. [The effectiveness of problem solving skills on the quality of life and self-esteem of MS patients]. J New Ideas Psychol. 2015;1(1):38- 29. (Persian)
31. 30. Mohammadi Y. Malmir T, Gozzari M. [The effect of neurofeedback on anxiety and dare in people with panic disorder]. J Neu. 2015;2(5):80-69. (Persian)
32. 31. Vargas DL, Tyor WR. "Update on disease-modifying therapies for multiple sclerosis." J Inves Med. 2017;65(5):883-891.
33. 32. Orki M, Dhtaj M, Mahdi Zadeh A. [Effect of neurofeedback treatment on depression, anxiety, stress and abdominal pain in patients with chronic abdominal pain]. J Neu. 2015;2(3):60-45. (Persian)
34. 33. Janardhan V, Bakshi R. Quality of Life in patients with multiple sclerosis: The impact of fatigue and depression. J Neu Sci. 2002;205:51-58.
35. 34. Benito-Leo’n J, Morales JM, Rivera-Navarro A, Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Dis Reh. 2003;25:1291-303.
36. 35. Soleimani I, Habibi M, Bashpour S. [The effectiveness of controlling the quality of life of patients with multiple sclerosis]. J of Beh Sci Res. 2012;10(7):756- 746. (Persian)
37. 36. Lackner N, Unterrainer HF, Skliris D, Wood G, Wallner-Liebmann SJ, Neuper C. & Gruzelier JH. "The effectiveness of visual short-time neurofeedback on brain activity and clinical characteristics in alcohol use disorders: Practical issues and results". Clin EEG Neu. 2016;47(3):188-195.
38. 37. Pour Ebrahimi M, Amir Teymoori R, Bani Assadi H. [The efficacy of meta-cognitive therapy of neurofeedback and fluvoxamine on the anxiety, depression and symptoms of people with obsessive-compulsive disorder]. J Thoug Behav. 2015;10(38):46-37. (Persian)
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
